Definitive Contract 75D30124C18824
Award Date 9/30/24
Potential Completion Date 9/29/26
Potential Value $1.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Collins, CO 80521, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,333,872.00 firm fixed price federal contract awarded by the Centers for Disease Control and Prevention (CDC) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a renowned academic medical center in Boston, Massachusetts. The contract has a period of performance through September 29, 2026. The contract involves MGH conducting research and providing specialized services related to Lyme disease epidemiology and surveillance. MGH is working with...
- This federal contract award is for the project "HARNESSING ELECTRONIC HEALTH RECORDS FOR SURVEILLANCE OF LYME DISEASE", with a ceiling value of $1,009,763.91. The prime contractor is The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit academic medical center. MGH has two major subcontractors: Mainehealth, a non-profit integrated health system, and Tufts Medical Center, another non-profit academic medical center. The funding agency is...
- This is a $620,310.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced oral bait. The contract, which has an ultimate completion date of August 24, 2026, is intended to support the CDC's vector-borne disease program by controlling tick populations and reducing Lyme disease incidence. Genesis Laboratories has previously conducted...
- This is a $9,914,240.00 cost-reimbursement contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Health Research, Inc., a non-profit organization based in Menands, New York. The contract is for research to discover and characterize human B cell epitopes on bacterial surface antigens involved in immunity to Borrelia burgdorferi, the causative agent of...
- This is a $10,279,321.93 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Health Research, Inc. (HRI), a non-profit organization. The contract is for "LYME DISEASE: B CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION" and has a completion date of September 15, 2025. The contract is a cost-no-fee arrangement and was not set aside for any specific business...
- <p>This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to the Bay Area Lyme Foundation, a non-profit organization. The contract is for $249,520.00 and provides scientific advising and technical assistance with biorepository samples for the LDB LYMEX DIAGNOSTICS PRIZE AND LYMEX DXD PILOT program. The contract does not have a set-aside designation and is scheduled for completion by September 22, 2025.</p>
- Marshfield Clinic, Inc. has been awarded a definitive cost-no-fee contract from the Department of Health and Human Services Centers for Disease Control and Prevention valued at up to $424,312. The contract calls for an epidemiologic assessment of Lyme disease diagnoses in electronic health records to support the agency's objectives. As the prime contractor, Marshfield Clinic will analyze Lyme disease data extracted from electronic health records to provide epidemiologic insights. The contract...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $91,194.89 firm-fixed-price purchase order contract to the Old Dominion University Research Foundation (ODURF) to use an updated version of the LYMESIM computer simulation model for Lyme disease prevention strategies. This work was not set aside for any special program. ODURF is a non-profit organization that manages a diverse portfolio of federal contracts and grants across scientific and technical domains, frequently...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, to enhance the serum repository for Lyme disease. The contract has a ceiling value of $237,421.00 and a completion date of September 24, 2022. Marshfield Clinic has a long history of partnering with the CDC and other federal agencies on public health initiatives, including vaccine safety monitoring and COVID-19 research. This...
- This is a purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Lyme Computer Systems, Inc. for MATLAB software licenses and related services. The contract has a total ceiling value of $3,640.14 and a period of performance through June 30, 2024. Lyme Computer Systems, Inc. is a for-profit subchapter S corporation that specializes in providing IT solutions and software to federal agencies. While this contract does not have a small business...